Doctors have begun noticing a trend: they all seem to get full before finishing dinner, and it's likely thanks to drugs like ...
These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...
19h
Axios on MSNWegovy and Ozempic stars dim amid overuse concernsThe luster is starting to wear off GLP-1 weight-loss drugs including Wegovy and Ozempic as more clinicians warn patients ...
There's a growing body of evidence that gold nanoparticles can offer significant, targeted weight loss that focuses on fat ...
The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...
There's growing evidence to suggest that GLP-1 drugs, which include semaglutide, may be useful for treating alcohol use disorder.
Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...
There are no studies documenting the percentage of doctors taking the drugs. But physicians “are a good litmus test for drugs ...
"It's frankly scary what people will put up with when they're losing weight" Dr Michael Crotty on the rollout of Mounjaro ...
WEIGHT-loss jabs are taking the world by storm, with a staggering half a million of us now using them. The injections have ...
Plastic surgeons are seeing more patients opting for breast reductions and dissolving facial fillers. They reveal that patients want a more natural, athletic and effortless look.
Add surgical tweaks to fix so-called "Ozempic face" to the list of top trending cosmetic procedures, as tallied by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results